| 8.45 Data as of Jun 18 |  -0.16 / -1.86%Today’s Change | 3.10 Today|||52-Week Range 10.37 | +78.65% Year-to-Date |
| Morning Market Losers Jun 13 / Benzinga | This Metric Suggests You're Right to Own Cornerstone Therapeutics. Jun 06 / MotleyFool.com |
| Previous close | 8.61 |
| Today’s open | 8.55 |
| Day’s range | 8.41 - 8.55 |
| Volume | 99,089 |
| Average volume (3 months) | 84,572 |
| Market cap | $230.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -1,433.33% |
| Earnings growth (this year) | +30.51% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +14.46% |
| P/E ratio | NM |
| Price/Sales | 1.06 |
| Price/Book | 1.37 |
| Today’s change | Today’s % change | |
|---|---|---|
| STSIStar Scientific Inc | +0.05 | +3.57% |
| INSYInsys Therapeutics I... | +0.04 | +0.37% |
| RGENRepligen Corp | +0.28 | +3.66% |
| SVASinovac Biotech Ltd | +0.07 | +1.76% |
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.17 |
| Annual revenue (last year) | $116.1M |
| Annual profit (last year) | -$11.9M |
| Net profit margin | -10.24% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Craig A. Collard |
President Kenneth R. McBean |
Corporate headquarters Cary, North Carolina |
.
